Production (Stage)
HCA Healthcare, Inc.
HCA
$376.59
-$0.05-0.01%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 5.65% | 9.88% | 3.73% | -0.57% | -4.59% |
Total Depreciation and Amortization | 8.38% | 7.64% | 6.81% | 5.10% | 4.11% |
Total Amortization of Deferred Charges | 5.71% | 0.00% | 6.06% | 12.90% | 12.90% |
Total Other Non-Cash Items | 24.28% | -1.37% | 65.84% | 70.72% | 29.42% |
Change in Net Operating Assets | -2,396.36% | 76.81% | 129.51% | -539.43% | 106.29% |
Cash from Operations | -3.97% | 11.48% | 14.49% | -2.36% | 12.44% |
Capital Expenditure | -1.78% | -2.76% | 3.24% | 3.82% | 1.40% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | 35.55% | 58.11% | -75.68% | -176.72% | -82.79% |
Divestitures | -47.04% | 69.95% | -58.07% | -76.10% | -75.65% |
Other Investing Activities | 23.81% | 8.40% | -306.82% | -975.00% | -740.00% |
Cash from Investing | 0.14% | 7.22% | -14.87% | -37.28% | -37.19% |
Total Debt Issued | 30.90% | 132.48% | 123.12% | 84.05% | 364.92% |
Total Debt Repaid | 20.39% | -122.40% | -108.78% | -7.42% | -897.19% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -77.76% | -58.54% | -18.82% | -15.56% | 27.85% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -2.09% | -4.39% | -4.26% | -3.51% | -3.07% |
Other Financing Activities | -13.50% | -15.05% | 21.29% | 29.48% | 28.10% |
Cash from Financing | -6.02% | -11.92% | 29.33% | 26.29% | 32.63% |
Foreign Exchange rate Adjustments | 400.00% | -114.29% | -28.57% | -100.00% | 87.50% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -150.68% | 3,596.30% | 1,949.07% | -875.00% | 128.91% |